MedTrace Logo

Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles

NCT01795417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-08-07

No results posted yet for this study

Summary

To evaluate the wrinkle-reducing effects of 3.25-MHz radiofrequency (RF) energy delivered in 4 weekly applications to human periorbital skin area by grating pre- and 90-days post treatment photographs on the Fitzpatrick Wrinkle Severity Scale (FWSS) by three blinded evaluators.

Conditions

  • Periorbital Wrinkles

Interventions

DEVICE

RF XP200

Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device

DEVICE

XP200 RF device

4 RF treatments of periorbital region on one side of the face

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Principal Investigators

  • Georgi Petkov · BTL Industries Ltd.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-12-31
Completion
2013-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795417 on ClinicalTrials.gov